Clinical trials
Withdrawn Metabolic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 2 |
| Eledon Pharmaceuticals | 1 |
| Massachusetts General Hospital | 1 |
| National Center for Complementary and Integrative Health (NCCIH) | 1 |
| Neurocrine Biosciences | 1 |
| New York Presbyterian Brooklyn Methodist Hospital | 1 |
| University of California, Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 8 |
| Endocrine System Diseases | 2 |
| Hyperglycemia | 2 |
| Obesity | 2 |
| Pathologic Processes | 2 |
| Adrenal Gland Diseases | 1 |
| Adrenal Hyperplasia, Congenital | 1 |
| Adrenocortical Hyperfunction | 1 |
| Adrenogenital Syndrome | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.